{"id":"cyverine","rwe":[],"tags":[{"label":"cyverine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["cyverine"],"offLabel":[],"synonyms":["cyverine"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"cyverine","explanation":"Cyverine's mechanism of action is not well described, but it is thought to work by interacting with a specific target in the body. This interaction is believed to produce a therapeutic effect, but the exact details of how it works are not yet clear. More research is needed to fully understand how cyverine produces its effects.","oneSentence":"Unfortunately, the mechanism of action of cyverine is not well understood.","technicalDetail":"Unfortunately, the specific target and molecular mechanism of cyverine are not well characterized, and further research is needed to elucidate its pharmacology."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/772","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=cyverine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:22:56.132885","biosimilars":[],"competitors":[],"genericName":"cyverine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"XN4L2RKV9Q","PUBCHEM_CID":"10859"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"cyverine","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Cyverine is a small molecule drug in the cyverine class, but information on its target, approved indications, and commercial status is not available. As a result, its mechanism of action, pharmacokinetics, and safety profile are unknown. Further research is needed to understand the properties and potential uses of cyverine. Without more information, it is difficult to provide a comprehensive summary of this drug. More data is required to determine its clinical utility and potential risks.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}